2Suppliers
8Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Precipio, Inc. (PRPO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

13Total relationships
2Distinct source URLs
5High confidence
0.777Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Precipio, Inc. Suppliers

TickerNameConfidenceEvidence
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from PRPO graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from PRPO graph: Reciprocal relationship from MYGN g…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from PRPO graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from PRPO graph: Reciprocal relationship from SNYN…

Precipio, Inc. Customers

TickerNameConfidenceEvidence
ONE-CUSTOMER ONE-CUSTOMER 92% At December 31, 2024, one customer accounted for approximately 29% of our total accounts receivable.
THREE-CUSTOMERS THREE-CUSTOMERS 92% At December 31, 2025, we had three customers who each individually represented more than 10% of our total accounts receivable.
MYGN Myriad Genetics, Inc. 72% to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them, or those to whom they communicate it, from using that technology or in…
MYGN Myriad Genetics, Inc. 72% Reciprocal relationship from MYGN graph: Reciprocal relationship from PRPO graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from PRPO graph: Reciprocal relationship from MYGN g…
SNYNF Sanofi 72% to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them, or those to whom they communicate it, from using that technology or in…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from PRPO graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from PRPO graph: to be lawfully obtained or indepe…
UNH UnitedHealth Group Incorporated 62% Reciprocal relationship from UNH graph: Reciprocal relationship from PRPO graph: e as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2026 ​ ​ ​ 2027 ​ ​ ​ 2028 ​ ​ ​ Total DECD loan ​ $ 33 ​ $ 34 ​ $ 16 …
UNITEDHEALTH-GROUP UNITEDHEALTH-GROUP 62% e as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 2026 ​ ​ ​ 2027 ​ ​ ​ 2028 ​ ​ ​ Total DECD loan ​ $ 33 ​ $ 34 ​ $ 16 ​ $ 83 ​ ​ 6 . ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES. Accrued expenses a…

Precipio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PRPO-DEBT-11903 Warrants outstanding: 10000 90% xbrl warrant detail from xbrl 2026-03-31.
PRPO-DEBT-11904 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
PRPO-DEBT Debt stack $325,000 90% Market cache reports total debt of $325,000.

Precipio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Precipio, Inc..

Precipio, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Precipio, Inc..

Precipio, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BNTC Benitec Biopharma Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
CALC CalciMedica, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
🔐
PRPO
Unlock PRPO Supply Chain Data
Verified relationships include:
MYGNMyriad Genetics, Inc.Supplier72%
SNYNFSanofiSupplier72%
ONE-CUSTOMERONE-CUSTOMERCustomer92%
THREE-CUSTOMERSTHREE-CUSTOMERSCustomer92%
+9 more relationships locked
Subscribe, View plans →